For private equity and venture capital investors alike, there are five key trends presenting both headwinds and tailwinds that may impact investment flows into 2022.
This article reviews real-world examples of product failures, presents reasons for these failures and provides potential solutions better governance, collaboration, and data gathering throughout the product lifecycle.
China’s medical device market has grown significantly over the last five years, but with that growth comes some pitfalls.
The market dynamics for telehealth and virtual care continue to evolve, and virtual care ecosystem players must understand how consumers have experienced these changes to better position themselves and design their solutions.
The talent behind a company’s solutions is its biggest competitive advantage. For many medtech companies, attracting candidates requires taking a fresh look at the recruiting and retention process.
Although opportunities in Japan are still considerable, foreign device companies need to do their homework to be successful.
Intensive chemistry requirements are creating massive data sets of chemicals, all of which need to be assessed for biological safety. This deluge of data is making equivocal results far more common than ever before. Fortunately, manufacturers can take steps to mitigate risk and support the safety of their products.
The application of AI in telehealth to allow doctors to make real-time, data-driven rich choices is a key component in generating a better patient experience and improved health outcomes.
The mHealth industry is rapidly disrupting traditional healthcare delivery by leveraging the power of mobile communication technologies and wearable devices.
This article highlights what manufacturers should prioritize and areas in which new information may still emerge, along with providing a starting point for businesses that need to familiarize themselves with the UK Conformity Assessed marking requirements.
